603880.SH
南卫股份
SSE · Healthcare · Medical - Instruments & Supplies · CN
CNY 8.68
−0.23%Year over year
Reported trailing growth
- Revenue
- -7.8%
- EBITDA
- —
- EBIT
- +56.6%
- EPS
- +50.8%
- Free cash flow
- +18.1%
- Operating cash flow
- +4.6%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +3.3%
- EBITDA
- +67.9%
- EBIT
- +53.3%
- Net income
- +46.7%
- EPS
- +47.0%
- Free cash flow
- +11.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026